tetano
Editor, Senior Moderator
J Infect Chemother
. 2023 Jun 12;S1341-321X(23)00149-6.
doi: 10.1016/j.jiac.2023.06.006. Online ahead of print. Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
Kensuke Shoji[SUP] 1 [/SUP], Yusuke Asai[SUP] 2 [/SUP], Takayuki Akiyama[SUP] 3 [/SUP], Shinya Tsuzuki[SUP] 4 [/SUP], Nobuaki Matsunaga[SUP] 3 [/SUP], Setsuko Suzuki[SUP] 5 [/SUP], Noriko Iwamoto[SUP] 5 [/SUP], Takanori Funaki[SUP] 6 [/SUP], Isao Miyairi[SUP] 7 [/SUP], Norio Ohmagari[SUP] 2 [/SUP]
Affiliations
Clinical efficacy of remdesivir in children with COVID-19 is unclear. This propensity-score-matched retrospective cohort study of children with COVID-19 showed that the rate of patients achieving defervescence on Day 4 was higher in the remdesivir group than in the non-remdesivir group, but was not statistically different (86.7% vs 73.3%, P = 0.333).
Keywords: Children; Coronavirus disease 2019; Defervescence; Remdesivir; Severe acute respiratory syndrome coronavirus 2.
. 2023 Jun 12;S1341-321X(23)00149-6.
doi: 10.1016/j.jiac.2023.06.006. Online ahead of print. Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis
Kensuke Shoji[SUP] 1 [/SUP], Yusuke Asai[SUP] 2 [/SUP], Takayuki Akiyama[SUP] 3 [/SUP], Shinya Tsuzuki[SUP] 4 [/SUP], Nobuaki Matsunaga[SUP] 3 [/SUP], Setsuko Suzuki[SUP] 5 [/SUP], Noriko Iwamoto[SUP] 5 [/SUP], Takanori Funaki[SUP] 6 [/SUP], Isao Miyairi[SUP] 7 [/SUP], Norio Ohmagari[SUP] 2 [/SUP]
Affiliations
- PMID: 37315843
- DOI: 10.1016/j.jiac.2023.06.006
Clinical efficacy of remdesivir in children with COVID-19 is unclear. This propensity-score-matched retrospective cohort study of children with COVID-19 showed that the rate of patients achieving defervescence on Day 4 was higher in the remdesivir group than in the non-remdesivir group, but was not statistically different (86.7% vs 73.3%, P = 0.333).
Keywords: Children; Coronavirus disease 2019; Defervescence; Remdesivir; Severe acute respiratory syndrome coronavirus 2.